仿制药立项调研
| 药品名称 |
中国上市 |
已过评 |
未过评 |
仿制药申请 |
一致评价补充申请 |
BE登记 |
参比制剂 |
国家集采 |
| 吲哚美辛 |
89 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
| 环丙沙星 |
89 |
12 |
0 |
15 |
10 |
10 |
7 |
8 |
| 克林霉素磷酸酯 |
89 |
25 |
0 |
19 |
25 |
19 |
6 |
12 |
| 甲氧氯普胺 |
78 |
8 |
0 |
7 |
12 |
9 |
2 |
0 |
| 西地那非 |
71 |
88 |
0 |
49 |
109 |
56 |
14 |
19 |
| 琥乙红霉素 |
70 |
1 |
0 |
7 |
1 |
4 |
7 |
0 |
| 辛伐他汀 |
69 |
26 |
0 |
138 |
25 |
23 |
7 |
10 |
| 呋噻米 |
69 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| 硫糖铝 |
62 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
| 格列本脲 |
56 |
0 |
0 |
2 |
3 |
0 |
2 |
0 |
检索全部仿制药立项调研